ArticleBMC primary care2026
War and wellness: health-system barriers and access-constrained medication adherence for diabetes, hypertension, and dyslipidemia in the West bank, Palestine (2025).
Article in BMC primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetes (15% prevalence), hypertension (24%), and dyslipidemia (66.4%) are major health challenges in Palestine, with poor control rates (≤ 16.7%) due to low medication adherence. Chronic disease management is further hindered by socioeconomic barriers, treatment complexity, and geopolitical instability, including restricted healthcare access. This study assesses adherence levels and identifies key barriers; such as cost, psychological stress, and war-related disruptions, to inform targeted interventions in conflict-affected region.
methodsThis cross-sectional study recruited 423 adult patients with diabetes, hypertension, and/or dyslipidemia from West Bank primary health care centers (March–June 2025) via convenient sampling. Using the MARS-10 questionnaire, adherence (primary outcome) and barriers (cost, conflict-related access, side effects) were assessed. A two-stage sampling approach selected 3 governorates (north/center/south) and 6 clinics (central/peripheral). Data collection involved structured interviews for illiterate participants.
resultsApparent medication adherence was low, largely reflecting access-constrained treatment interruption due to medication shortages and health-system disruption rather than behavioral non-adherenc: only 10.3% for diabetes, 10.0% for hypertension, and 7.8% for dyslipidemia. Key barriers included high medication costs (44.4%), multiple daily doses (38.5%), war-related unemployment (37.6%), and psychological distress (depression: 14.7%). Age, education, and income significantly influenced adherence (p < 0.05), while war-specific disruptions (checkpoints, clinic closures) they were not independently associated with Forced treatment interruptionin adjusted analyses; however, war-related unemployment emerged as a significant predictor of poor adherence. Findings highlight the urgent need for targeted interventions addressing financial, regimen complexity, and psychosocial challenges in conflict zones.
conclusionChronic illness medication adherence in conflict zones is low due to systemic, financial, and emotional barriers. Effective solutions require psychosocial support, simplified regimens, and culturally sensitive approaches. Further research should explore long-term impacts of trauma, health beliefs, and adaptive behaviors to develop context-specific interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.